Related Experiment Video
Updated: Sep 17, 2025
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
The emerging fungal pathogen Cryptococcus gattii: Epidemiology, pathogenesis, immunomodulatory attributes, and drug
1College of Pharmaceutical Sciences, Southwest University, Chongqing, China.
Abstract:
The emerging fungal pathogen, Cryptococcus gattii, causes infections in both immunocompromised and immunocompetent individuals, often resulting in high mortality rates. While Cryptococcus neoformans is predominantly associated with cryptococcosis in immunocompromised patients, the significance of C. gattii infections has garnered attention due to its prevalence among seemingly healthy individuals. Notably, C. gattii exhibits distinct epidemiological patterns, geographic distribution, genotypes, and phenotypes compared to C. neoformans. However, the comprehension of C. gattii's virulence characteristics, regulatory mechanisms, and therapeutic avenues has lagged behind those of C. neoformans. The less robust clinical and epidemiological data, coupled with the limitations of effective treatment options, underscore the urgency in addressing C. gattii as a serious public health threat. In this review, I discuss the epidemiology, virulence factors, regulatory mechanisms, immunomodulatory attributes, and drug susceptibility of C. gattii. This comprehensive discussion aims to enhance our understanding of this emerging fungal pathogen and potentially contribute to the development of more effective prevention and management strategies.
Insights
Cryptococcus gattii is an emerging fungal pathogen causing severe infections in healthy and immunocompromised individuals. Further research is crucial for developing effective treatments against this significant public health threat.
Area of Science:
- Mycology
- Infectious Diseases
- Public Health
Background:
- Cryptococcus gattii is an emerging fungal pathogen causing infections in both immunocompromised and immunocompetent individuals.
- Unlike Cryptococcus neoformans, C. gattii infections are increasingly recognized in healthy individuals, highlighting distinct epidemiological patterns and virulence.
- Understanding C. gattii is critical due to its high mortality rates and limited therapeutic options.
Purpose of the Study:
- To provide a comprehensive review of Cryptococcus gattii.
- To discuss its epidemiology, virulence factors, regulatory mechanisms, immunomodulatory properties, and drug susceptibility.
- To enhance understanding and inform strategies for prevention and management.
Main Methods:
- Literature review of epidemiological data.
- Analysis of studies on C. gattii virulence factors and regulatory mechanisms.
- Examination of research on immunomodulatory attributes and drug susceptibility.
Main Results:
- C. gattii presents unique epidemiological and genotypic characteristics compared to C. neoformans.
- Knowledge regarding C. gattii's virulence and therapeutic targets is less developed than for C. neoformans.
- There is an urgent need for more clinical and epidemiological data and improved treatment options.
Conclusions:
- Cryptococcus gattii poses a significant and growing public health threat.
- Further research into C. gattii's biology and pathogenesis is essential.
- Enhanced understanding will facilitate the development of effective prevention and treatment strategies.
Related Concept Videos
01:28Fungal Phylum Microsporidia
01:29Fungal Group Zygomycota
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...